AR023477A1 - Suplemento dietario de leches fermentadas, para la prevencion de la osteoporosis - Google Patents

Suplemento dietario de leches fermentadas, para la prevencion de la osteoporosis

Info

Publication number
AR023477A1
AR023477A1 ARP000101708A ARP000101708A AR023477A1 AR 023477 A1 AR023477 A1 AR 023477A1 AR P000101708 A ARP000101708 A AR P000101708A AR P000101708 A ARP000101708 A AR P000101708A AR 023477 A1 AR023477 A1 AR 023477A1
Authority
AR
Argentina
Prior art keywords
grains
weight
substance
yeasts
osteoporosis
Prior art date
Application number
ARP000101708A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of AR023477A1 publication Critical patent/AR023477A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1232—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt in powdered, granulated or dried solid form
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Abstract

Se describe un proceso para la manufactura de suplementos dietarios (integradores de alimentos) mediante una fermentacion natural, que incluye lossiguientes pasos: a) preparar una mezcla a una temperatura de 18sC, que contiene uno o más tipos de leche pasteurizada de origen animal; b) Introducir en dichomaterial básicode 1,5 a 4,5% en peso, de granos de polisacáridos, principalmente constituidos por bacterias amistosas; c) mantener la sustanciaanteriormente mencionada a una temperatura de 18 a 25sC durante un primer período de 6 a 12 horas y seguidamente adicionar una cantidad de 1 a 3% en peso, deuna segunda recoleccion de granos de polisacáridos, formados principalmente por levaduras; d) mantener la sustancia a de 18 a 25sC durante un segundoperíodo de 6 a 12 horas, mediante la renovada adicion de 2,5 a 6,5% en peso, de granos formados principalmente por levaduras, después de lo cual se adicionan algunos minerales (calcio, magnesio, etc.) en una proporcion de 0,2 a 1,2% en peso; e) separacion por filtrado,de diversos componentes de la sustancia, entrelas cuales hay una matriz residual compuesta por granos de polisacáridos que contienen bacterias y levaduras; f) secado de la sustancia, frecuentefiltracion, obteniéndose un polvo fino; g) Preparacion de diversos suplementos dietarios, presentados en tabletas o sachets o como otras formulaciones,utiles en el tratamiento de la osteoporosis y otras condiciones degenerativas.
ARP000101708A 1999-04-13 2000-04-13 Suplemento dietario de leches fermentadas, para la prevencion de la osteoporosis AR023477A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH68399 1999-04-13

Publications (1)

Publication Number Publication Date
AR023477A1 true AR023477A1 (es) 2002-09-04

Family

ID=4192730

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101708A AR023477A1 (es) 1999-04-13 2000-04-13 Suplemento dietario de leches fermentadas, para la prevencion de la osteoporosis

Country Status (24)

Country Link
US (1) US6511685B1 (es)
EP (1) EP1085816B1 (es)
JP (1) JP4231208B2 (es)
KR (1) KR20010072587A (es)
CN (1) CN1300187A (es)
AR (1) AR023477A1 (es)
AT (1) ATE249147T1 (es)
AU (1) AU775104B2 (es)
BR (1) BR0006040A (es)
CA (1) CA2334877C (es)
DE (1) DE60005104T2 (es)
DK (1) DK1085816T3 (es)
EE (1) EE200000713A (es)
ES (1) ES2204569T3 (es)
HU (1) HUP0103895A3 (es)
IL (1) IL139853A0 (es)
IS (1) IS5741A (es)
NO (1) NO20006284L (es)
PL (1) PL344670A1 (es)
PT (1) PT1085816E (es)
SK (1) SK18862000A3 (es)
TN (1) TNSN00078A1 (es)
TR (1) TR200003689T1 (es)
WO (1) WO2000060950A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100866008B1 (ko) * 1999-10-19 2008-10-29 메이지 데어리즈 코포레이션 대사성 골질환의 예방 치료약
SE0201214D0 (sv) * 2002-04-23 2002-04-23 Jafar Mahdavi Multicultural fermented yoghurt
GB0217225D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
RU2338511C2 (ru) * 2003-04-09 2008-11-20 Дольхаи Клиника Эгесшегидьи Кфт. Композиция для половой гигиены
JP5048246B2 (ja) * 2003-08-26 2012-10-17 日本ケフィア株式会社 スキンケア用の内服組成物
EP1806976B1 (en) * 2004-10-22 2014-01-29 Unilever N.V. Granular cooking aid comprising microbial encapsulates, and cubes and tablets comprising such granular cooking aid
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
DE102005053725A1 (de) * 2005-11-10 2007-05-24 St. Leonhardsquelle Gmbh & Co. Kg Milchprodukt umfassend Stutenmilch und Ziegenmilch, Verfahren zu dessen Herstellung und deren Verwendung
CA2686922C (en) 2007-05-09 2015-06-30 Nestec S.A. Freeze-dried, aerated fruit or vegetable compositions and methods of making thereof
EP2154982B1 (en) 2007-05-09 2014-06-04 Nestec S.A. Freeze-dried, aerated dairy or dairy-substitute compositions and methods of making thereof
KR100940125B1 (ko) * 2007-08-24 2010-02-02 국민대학교산학협력단 락토바실러스 카세이에 의한 우유 발효물을 유효성분으로포함하는 골 대사 개선용 조성물
ITMI20122267A1 (it) * 2012-12-28 2014-06-29 Granarolo S P A Miscela aromatizzante per la produzione di mozzarelle.
DE102017202134A1 (de) 2017-02-10 2018-08-16 Intercell Pharma Gmbh Präparat zur Behandlung der nachteiligen Begleiterscheinungen von Magensäureblockern
TWI604052B (zh) 2017-02-20 2017-11-01 景岳生物科技股份有限公司 促進骨質再生的植物乳桿菌菌株ｇｍｎｌ－６６２及其組合物
CN108624520B (zh) * 2017-03-16 2022-01-25 景岳生物科技股份有限公司 促进骨质再生的植物乳杆菌菌株gmnl-662及其组合物
CN108486018B (zh) * 2018-05-03 2021-05-11 上海理工大学 一种具有缓解骨吸收症状的短乳杆菌
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
EP3986163A2 (en) * 2019-06-19 2022-04-27 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
WO2023092150A1 (en) * 2021-11-22 2023-05-25 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1349300A (fr) * 1962-11-27 1964-01-17 Eurorga Produit alimentaire en provenance du lait
EP0148300B1 (de) * 1984-01-10 1989-04-05 Bio-Industries Gmbh Sanofi Verfahren zum Herstellen von Kefir
US4702923A (en) * 1985-10-08 1987-10-27 Sennosuke Tokumaru Lyophilized kefir yoghurt health food
US4902517A (en) * 1987-12-28 1990-02-20 The Calpis Food Industry Co., Ltd. Processes for producing milk-derived alcoholic beverages
JPH0626505B2 (ja) * 1988-06-16 1994-04-13 株式会社ヤクルト本社 ケフィア様乳製品の製造法
FR2672612B1 (fr) * 1991-02-08 1993-06-04 Rochade Procede de fabrication d'un nouveau levain lactique, nouveau levain obtenu, fabrication de produits alimentaires a partir de ce levain et produits obtenus.
JPH09191852A (ja) * 1996-01-19 1997-07-29 Sennosuke Tokumaru 健康食品
US5820903A (en) * 1997-06-30 1998-10-13 General Mills, Inc. Calcium fortified yogurt and methods of preparation
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof

Also Published As

Publication number Publication date
PT1085816E (pt) 2004-02-27
EP1085816B1 (en) 2003-09-10
JP2002540807A (ja) 2002-12-03
JP4231208B2 (ja) 2009-02-25
DE60005104T2 (de) 2004-08-19
DK1085816T3 (da) 2004-01-26
HUP0103895A3 (en) 2003-02-28
SK18862000A3 (sk) 2001-06-11
NO20006284L (no) 2001-01-29
ATE249147T1 (de) 2003-09-15
KR20010072587A (ko) 2001-07-31
TR200003689T1 (tr) 2001-07-23
IL139853A0 (en) 2002-02-10
IS5741A (is) 2000-11-28
NO20006284D0 (no) 2000-12-11
US6511685B1 (en) 2003-01-28
PL344670A1 (en) 2001-11-19
CA2334877C (en) 2009-06-16
DE60005104D1 (de) 2003-10-16
CA2334877A1 (en) 2000-10-19
CN1300187A (zh) 2001-06-20
WO2000060950A1 (en) 2000-10-19
ES2204569T3 (es) 2004-05-01
EE200000713A (et) 2002-04-15
HUP0103895A2 (hu) 2002-02-28
BR0006040A (pt) 2001-03-13
AU775104B2 (en) 2004-07-15
TNSN00078A1 (fr) 2005-11-10
EP1085816A1 (en) 2001-03-28
AU4311800A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
AR023477A1 (es) Suplemento dietario de leches fermentadas, para la prevencion de la osteoporosis
Glick et al. Effect of tannic acid and related compounds on the absorption and utilization of proteins in the rat
KR101087019B1 (ko) 해산어류용 양식 사료 첨가제 및 이를 포함하는 해산어류 양식용 사료
TWI580361B (zh) 用於降低反芻動物甲烷生成之方法
CN100362091C (zh) 硒酵母产物,制备硒酵母产物的方法以及所述产物在制备食品、膳食补充品或药品中的用途
Pascual et al. Litopenaeus vannamei juveniles energetic balance and immunological response to dietary protein
BR112021006787A2 (pt) composições e métodos para reduzir emissões atmosféricas de metano e óxido nitroso
CN105475636A (zh) 一种水溶性大蒜素混合物、制备方法及用途
CN105614161A (zh) 一种鱼虾用饲料及其制备方法
CN112294802A (zh) 降低鱼苗运输损耗的抗应激制剂及其制作工艺和使用方法
KR100913611B1 (ko) 광합성 세균을 이용한 어류용 사료첨가제 및 이를 포함하는사료
EP3270706A1 (en) Archaebacteria in bioactive animal feed, method of making the composition and methods employing the composition
CN108208458A (zh) 一种黑斑蛙蝌蚪开口饵料及其制备方法
KR101547922B1 (ko) 제독유황을 이용하여 제조된 기능성 유황쌀의 제조방법 및 용도
WO2004089106A2 (en) Tannin mixture used as additives
CN102669486A (zh) 虾专用型动物生命素及其制备方法
JPH09173016A (ja) クロレラエキス粉末の製造法
RU2499829C1 (ru) Способ получения комплексного кормового препарата с продуцентом лизина на основе corynebacterium glutamicum
KR20170031900A (ko) 해파리 발효물을 포함하는 질소 액상 비료 조성물, 및 이의 제조방법
CN116963607A (zh) 乳酸菌抑制产甲烷菌生长或减少甲烷排放的用途
CN101623061B (zh) 一种利用鲜蜂皇胎和蜂粮制备保健营养液的方法
KR100660478B1 (ko) 생약 추출물을 함유한 녹골 추출물의 제조방법과 이에 의해 제조된 녹골 추출물, 그리고 이를 함유하는 식품
RU2721800C1 (ru) Способ получения биокомпозитной кормовой добавки для сельскохозяйственных животных и птицы
CN110179127B (zh) 一种促铁锌钙吸收的营养强化剂及制备方法
RU2501303C2 (ru) Способ получения кормовой добавки для сельскохозяйственной птицы